Skip to main content
Top
Published in: Diabetologia 2/2020

01-02-2020 | Obesity

A prospective study of associations between in utero exposure to gestational diabetes mellitus and metabolomic profiles during late childhood and adolescence

Authors: Wei Perng, Brandy M. Ringham, Harry A. Smith, Gregory Michelotti, Katerina M. Kechris, Dana Dabelea

Published in: Diabetologia | Issue 2/2020

Login to get access

Abstract

Aims/hypothesis

This study aimed to: (1) identify metabolite patterns during late childhood that differ with respect to exposure to maternal gestational diabetes mellitus (GDM); (2) examine the persistence of GDM/metabolite associations 5 years later, during adolescence; and (3) investigate the associations of metabolite patterns with adiposity and metabolic biomarkers from childhood through adolescence.

Methods

This study included 592 mother–child pairs with information on GDM exposure (n = 92 exposed), untargeted metabolomics data at age 6–14 years (T1) and at 12–19 years (T2), and information on adiposity and metabolic risk biomarkers at T1 and T2. We first consolidated 767 metabolites at T1 into factors (metabolite patterns) via principal component analysis (PCA) and used multivariable regression to identify factors that differed by GDM exposure, at α = 0.05. We then examined associations of GDM with individual metabolites within factors of interest at T1 and T2, and investigated associations of GDM-related factors at T1 with adiposity and metabolic risk throughout T1 and T2 using mixed-effects linear regression models.

Results

Of the six factors retained from PCA, GDM exposure was associated with greater odds of being in quartile (Q)4 (vs Q1–3) of ‘Factor 4’ at T1 after accounting for age, sex, race/ethnicity, maternal smoking habits during pregnancy, Tanner stage, physical activity and total energy intake, at α = 0.05 (OR 1.78 [95% CI 1.04, 3.04]; p = 0.04). This metabolite pattern comprised phosphatidylcholines, diacylglycerols and phosphatidylethanolamines. GDM was consistently associated with elevations in a subset of individual compounds within this pattern at T1 and T2. While this metabolite pattern was not related to the health outcomes in boys, it corresponded with greater adiposity and a worse metabolic profile among girls throughout the follow-up period. Each 1-unit increment in Factor 4 corresponded with 0.17 (0.08, 0.25) units higher BMI z score, 8.83 (5.07, 12.59) pmol/l higher fasting insulin, 0.28 (0.13, 0.43) units higher HOMA-IR, and 4.73 (2.15, 7.31) nmol/l higher leptin.

Conclusions/interpretation

Exposure to maternal GDM was nominally associated with a metabolite pattern characterised by elevated serum phospholipids in late childhood and adolescence at α = 0.05. This metabolite pattern was associated with greater adiposity and metabolic risk among female offspring throughout the late childhood-to-adolescence transition. Future studies are warranted to confirm our findings.
Appendix
Available only for authorised users
Literature
4.
go back to reference Krishnaveni GV, Veena SR, Hill JC, Kehoe S, Karat SC, Fall CH (2010) Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children. Diabetes Care 33(2):402–404. https://doi.org/10.2337/dc09-1393 CrossRefPubMed Krishnaveni GV, Veena SR, Hill JC, Kehoe S, Karat SC, Fall CH (2010) Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children. Diabetes Care 33(2):402–404. https://​doi.​org/​10.​2337/​dc09-1393 CrossRefPubMed
5.
go back to reference Gautier JF, Wilson C, Weyer C et al (2001) Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes 50(8):1828–1833CrossRef Gautier JF, Wilson C, Weyer C et al (2001) Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes 50(8):1828–1833CrossRef
35.
go back to reference Cancello R, Tounian A, Poitou C, Clement K (2004) Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 30(3):215–227CrossRef Cancello R, Tounian A, Poitou C, Clement K (2004) Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 30(3):215–227CrossRef
48.
go back to reference Breton CV, Marsit CJ, Faustman E et al (2017) Small-magnitude effect sizes in epigenetic end points are important in children’s environmental health studies: the Children’s Environmental Health and Disease Prevention Research Center’s Epigenetics Working Group. Environ Health Perspect 125(4):511–526. https://doi.org/10.1289/ehp595 CrossRefPubMedPubMedCentral Breton CV, Marsit CJ, Faustman E et al (2017) Small-magnitude effect sizes in epigenetic end points are important in children’s environmental health studies: the Children’s Environmental Health and Disease Prevention Research Center’s Epigenetics Working Group. Environ Health Perspect 125(4):511–526. https://​doi.​org/​10.​1289/​ehp595 CrossRefPubMedPubMedCentral
58.
go back to reference Nestel P, Clifton P, Noakes M (1994) Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res 35(4):656–662PubMed Nestel P, Clifton P, Noakes M (1994) Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res 35(4):656–662PubMed
Metadata
Title
A prospective study of associations between in utero exposure to gestational diabetes mellitus and metabolomic profiles during late childhood and adolescence
Authors
Wei Perng
Brandy M. Ringham
Harry A. Smith
Gregory Michelotti
Katerina M. Kechris
Dana Dabelea
Publication date
01-02-2020
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2020
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-019-05036-z

Other articles of this Issue 2/2020

Diabetologia 2/2020 Go to the issue

Up Front

Up front

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.